Ghent University Academic Bibliography

Show Sort by

Your filters: cql: parent exact "JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY"

Add to list
Effects of biologics treatment in type 2-high chronic rhinosinusitis with nasal polyp patients

Sharon Van Nevel (UGent) , Tim Meese (UGent) , Gabriële Holtappels (UGent) , Natalie De Ruyck (UGent) , Stijn Vanhee (UGent) , Nan Zhang (UGent) , Filip Van Nieuwerburgh (UGent) and Claus Bachert (UGent)

(2023) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 151(2, Supplement 1). p.AB187-AB187
Add to list
- Journal Article
- A1
- open access
Complex regulation of alarmins S100A8/A9 and secretion via gasdermin D pores exacerbates autoinflammation in familial Mediterranean fever

Selina K. Jorch, Annika McNally, Philipp Berger, Jonas Wolf, Kim Kaiser, Andrian Chetrusca Covash, Stefanie Robeck, Isabell Pastau, Olesja Fehler, Saskia-L. Jauch-Speer, et al.

(2023) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY.
Add to list
- Journal Article
- A1
- open access
Endotypes of chronic rhinosinusitis based on inflammatory and remodeling factors

Xiangdong Wang, Yutong Sima, Yan Zhao, Nan Zhang (UGent) , Ming Zheng, Kun Du, Min Wang, Yue Wang, Yun Hao, Ying Li, et al.

(2023) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 151(2). p.458-468
Add to list
- Journal Article
- A1
A20 is a master switch of IL-33 signalling in macrophages and determines IL-33-induced lung immunity

Aurora Holgado Muñoz (UGent) , Zhuangzhuang Liu (UGent) , Aigerim Aidarova (UGent) , Christina Müller (UGent) , Mira Haegman (UGent) , Yasmine Driege (UGent) , Marja Kreike (UGent) , Charlotte Scott (UGent) , Inna Afonina (UGent) and Rudi Beyaert (UGent)

(2023) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY.
Add to list
Phase 3b randomized controlled trial of fevipiprant in patients with nasal polyposis with asthma (THUNDER)

Philippe Gevaert (UGent) , Claus Bachert (UGent) , Jorge Fernando Maspero, Mandy Cuevas, David Steele, Sandip Acharya and Pablo Altman

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 149(5). p.1675-1682.e3
Add to list
- Journal Article
- A1
- open access
Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study

Philippe Gevaert (UGent) , Rebecca Saenz, Jonathan Corren, Joseph K. Han, Joaquim Mullol, Stella E. Lee, Randall A. Ow, Rui Zhao, Monet Howard, Kit Wong, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 149(3). p.957-965.e3
Add to list
- Conference Paper
- C3
Mepolizumab and benralizumab reduce eosinophilic inflammation in nasal polyposis, do neutrophils take over?

Tim Delemarre (UGent) , Elien Gevaert (UGent) , Gabriële Holtappels (UGent) , Nan Zhang (UGent) , Hans Nauwynck and Claus Bachert (UGent)

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 149(2, Supplement S). p.AB161-AB161
Add to list
Online education yields significant gains in physicians' knowledge of eosinophil-associated disorders

Adriana Stan, Gillian Griffith, Juliette Vandenbroucque and Claus Bachert (UGent)

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 149(2, Supplement S). p.AB195-AB195
Add to list
- Conference Paper
- C3
Dupilumab improves objective, subjective, and health-related quality of life outcomes in chronic rhinosinusitis with nasal polyps (CRSwNP), regardless of BMI≥ 30 kg/m2 or weight≥ 90 kg : post-hoc analysis of the SINUS-24 and SINUS-52 studies

Seong Cho, Bruce Tan, Noam Cohen, Jody Tversky, Elina Toskala, Scott Nash, Haixing Zhang, Shahid Siddiqui, Asif H. Khan (UGent) , Juby Jacob-Nara, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 149(2). p.AB143-AB143
Add to list
- Conference Paper
- C3
Dupilumab leads to reduction of anosmia in patients with severe chronic rhinosinusitis with nasal polyps

Andrew Lane, Joaquim Mullol, Claire Hopkins, Wytske Fokkens, Stella Lee, Asif H. Khan (UGent) , Jérôme Msihid, Scott Nash, Shahid Siddiqui, Urvi Mujumdar, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 149(2). p.AB144-AB144

Academic Bibliography

Effects of biologics treatment in type 2-high chronic rhinosinusitis with nasal polyp patients

Complex regulation of alarmins S100A8/A9 and secretion via gasdermin D pores exacerbates autoinflammation in familial Mediterranean fever

Endotypes of chronic rhinosinusitis based on inflammatory and remodeling factors

A20 is a master switch of IL-33 signalling in macrophages and determines IL-33-induced lung immunity

Phase 3b randomized controlled trial of fevipiprant in patients with nasal polyposis with asthma (THUNDER)

Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study

Mepolizumab and benralizumab reduce eosinophilic inflammation in nasal polyposis, do neutrophils take over?

Online education yields significant gains in physicians' knowledge of eosinophil-associated disorders

Dupilumab improves objective, subjective, and health-related quality of life outcomes in chronic rhinosinusitis with nasal polyps (CRSwNP), regardless of BMI≥ 30 kg/m2 or weight≥ 90 kg : post-hoc analysis of the SINUS-24 and SINUS-52 studies

Dupilumab leads to reduction of anosmia in patients with severe chronic rhinosinusitis with nasal polyps

Contents

Support

Contact